ResMed Inc. balance sheet
At the end of its fiscal year on Jun 30, 2026, ResMed Inc. reported total assets of $8.97B and shareholders' equity of $6.59B. That works out to liabilities equal to 27% of assets, a current ratio of 3.10 (current assets ÷ current liabilities), long-term debt of 0.06× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.47B | $3.06B | $4.11B | $4.59B | $4.73B | $5.10B | $6.75B | $6.87B | $8.17B | $8.97B |
| Current assets | $1.64B | $1.07B | $1.15B | $1.52B | $1.57B | $1.93B | $2.37B | $2.36B | $3.51B | $4.32B |
| Cash & equivalents | $821.93M | $188.70M | $147.13M | $463.16M | $295.28M | $273.71M | $227.89M | $238.36M | $1.21B | $1.47B |
| Total liabilities | $1.51B | $1.00B | $2.04B | $2.09B | $1.84B | $1.74B | $2.62B | $2.01B | $2.21B | $2.38B |
| Current liabilities | $360.13M | $511.25M | $555.99M | $602.76M | $911.77M | $689.30M | $758.53M | $910.65M | $1.02B | $1.40B |
| Long-term debt | $1.08B | $269.99M | $1.26B | $1.16B | $643.35M | $765.33M | $1.43B | $697.31M | $658.39M | $399.42M |
| Shareholders' equity | $1.96B | $2.06B | $2.07B | $2.50B | $2.89B | $3.36B | $4.13B | $4.86B | $5.97B | $6.59B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 943819 (raw data). Most recent filing in this dataset: 10-Q filed Oct 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.